Upper Gastrointestinal Bleeding Clinical Trial
Official title:
Risk Stratification of Patients Presenting With Upper Gastrointestinal Bleeding to the Emergency Department Using AIMS65 Score and Red Cell Distribution Width
The rationale of this study in UGIB patients is to assess whether the prediction of mortality and morbidity using AIMS65 score improves when used in combination with RDW in the emergency department setting.
UGIB is a ticking time-bomb and emergency physicians are challenged to accurately assess risk, and aggressively manage patients with gastrointestinal bleeding within the stipulated time in the confines of emergency department. If not managed properly, it is associated with high mortality. Various clinical prediction scores help in risk stratifying such patients. Among the scores, AIMS65 score is the easy to use score and has good mortality predictive accuracy. RDW, once thought as marker of chronic blood loss has recently been identified as a good prognostic indicator as well as good predictor of mortality in conditions where there is acute blood loss. Both AIMS65 score and RDW value have been used separately as a predictor of morbidity and mortality in patients with UGIB. But there are not much studies so far evaluating their combined role as marker of predicting mortality as well as high risk among UGIB patients. Hence there is a need for a study to know the predictive value of combination of AIMS6S score and RDW in patients presenting to ED with symptoms of UGIB not been much studies comparing the relationship between RDW and upper GI bleed. The rationale of this study in UGIB patients is to assess whether the prediction of mortality and morbidity using AIMS65 score improves when used in combination with RDW in the emergency department setting. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02537353 -
Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip
|
Phase 4 | |
Recruiting |
NCT03624517 -
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
|
Phase 4 | |
Suspended |
NCT03337256 -
Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy
|
N/A | |
Completed |
NCT04472364 -
HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding
|
N/A | |
Completed |
NCT05563714 -
Anticoagulation With Enhanced Gastrointestinal Safety
|
N/A | |
Recruiting |
NCT00414713 -
Transfusion Requirements in Gastrointestinal (GI) Bleeding
|
Phase 4 | |
Completed |
NCT03680950 -
Efficacy Test of Real-Time Upper Gastrointestinal Monitoring System
|
N/A | |
Completed |
NCT05085405 -
Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial
|
N/A | |
Recruiting |
NCT06077916 -
Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy
|
N/A | |
Recruiting |
NCT04902248 -
OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding
|
N/A | |
Completed |
NCT02446678 -
Use of PillCam ESO2 in Triaging Patients Present With Upper GIB
|
N/A | |
Completed |
NCT05631639 -
Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study
|
N/A | |
Completed |
NCT02978391 -
UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD
|
N/A | |
Completed |
NCT00045799 -
Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill
|
Phase 3 | |
Recruiting |
NCT03090945 -
Pediatric Acute Gastrointestinal Bleeding Registry
|
||
Recruiting |
NCT06192355 -
Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding.
|
N/A | |
Recruiting |
NCT06297954 -
Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding
|
Phase 3 | |
Recruiting |
NCT03785080 -
Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients
|
N/A | |
Completed |
NCT03667703 -
Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease
|
Phase 4 | |
Terminated |
NCT02017379 -
Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.
|
N/A |